NCT02210494View on ClinicalTrials.gov

Safety of Secretrol® in the Short-term Management of Patients Undergoing Endoscopic Mucosal Resection (EMR)

PHASE1UnknownINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

August 31, 2015

Conditions
EMR Ulcer
Interventions
DRUG

Secretrol

Trial Locations (1)

64128

RECRUITING

Veteran's Administration Medical Center, Kansas City

Sponsors
All Listed Sponsors
lead

Effexus Pharmaceutical

INDUSTRY

NCT02210494 - Safety of Secretrol® in the Short-term Management of Patients Undergoing Endoscopic Mucosal Resection (EMR) | Biotech Hunter | Biotech Hunter